Literature DB >> 19487245

Estrogen receptor alpha, fos-related antigen-2, and c-Jun coordinately regulate human UDP glucuronosyltransferase 2B15 and 2B17 expression in response to 17beta-estradiol in MCF-7 cells.

Dong Gui Hu1, Peter I Mackenzie.   

Abstract

UDP-glucuronosyltransferase 2B15 and 2B17 expression is up-regulated by 17beta-estradiol in MCF-7 breast cancer cells, as assessed by quantitative real-time polymerase chain reaction. Using 5'-deletion mapping and site-directed mutagenesis, we demonstrate that 17beta-estradiol activation of UGT2B15 gene transcription is mediated by a 282-base pair fragment positioned -454 to -172 nucleotides from the translation start site. This region contains two putative activator protein-1 (AP-1) elements, one imperfect estrogen response element (ERE), and two consensus ERE half-sites. We propose that these five sites act as an estrogen response unit (ERU), because mutation in any site reduces activation of the UGT2B15 promoter by 17beta-estradiol. Despite the presence of two AP-1 elements, the UGT2B15 promoter is not responsive to the AP-1 activator phorbol 12-myristate 13-acetate. Although electrophoretic mobility shift assays (EMSA) indicate that the AP-1 proteins c-Jun and Fos-related antigen 2 (Fra-2) bound to the distal AP-1 site, binding of Jun or Fos family members to the proximal AP-1 site was not detected by EMSA. Chromatin immunoprecipitation assays showed a 17beta-estradiol-induced recruitment of estrogen receptor (ER) alpha, c-Jun, and Fra-2 to the 282-bp ERU. The involvement of these three transcription factors in the stimulation of UGT2B15 gene expression by 17beta-estradiol was confirmed by siRNA silencing experiments. Mutagenesis and siRNA experiments indicate that UGT2B17 expression is also regulated by 17beta-estradiol via the ERU, which is fully conserved in both promoters. Because UGT2B15 and UGT2B17 inactivate steroid hormones by glucuronidation, the regulation of their genes by 17beta-estradiol may maintain steroid hormone homeostasis and prevent excessive estrogen signaling activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487245     DOI: 10.1124/mol.109.057380

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

1.  Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer.

Authors:  Ebrahim Eskandari-Nasab; Mohammad Hashemi; Hamzeh Rezaei; Aliakbar Fazaeli; Mohammad Ali Mashhadi; Simin Sargholzaei Moghaddam; Farshid Arbabi; Mahdi Jahantigh; Mohsen Taheri
Journal:  Mol Biol Rep       Date:  2012-10-07       Impact factor: 2.316

2.  Sex differences in UDP-glucuronosyltransferase 2B17 expression and activity.

Authors:  Carla J Gallagher; Renee M Balliet; Dongxiao Sun; Gang Chen; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2010-09-01       Impact factor: 3.922

3.  Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancer.

Authors:  Hiroshi Hirata; Yuji Hinoda; Mohd S Zaman; Yi Chen; Koji Ueno; Shahana Majid; Christina Tripsas; Mary Rubin; Lee-May Chen; Rajvir Dahiya
Journal:  Carcinogenesis       Date:  2010-06-16       Impact factor: 4.944

4.  Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.

Authors:  Jacqueline A Shaw; Karen Page; Kevin Blighe; Natasha Hava; David Guttery; Becky Ward; James Brown; Chetana Ruangpratheep; Justin Stebbing; Rachel Payne; Carlo Palmieri; Suzy Cleator; Rosemary A Walker; R Charles Coombes
Journal:  Genome Res       Date:  2011-10-11       Impact factor: 9.043

5.  RNA inference-mediated caveolin-1 down-regulation decrease estrogen receptor alpha (ERα) signaling in human mammary epithelial cells.

Authors:  Xi Wang; Shuang Feng; Hong Zhang; Yang Wang; Yuying Cui; Zhaoyi Wang; Jing Liu; Wei Zou
Journal:  Mol Biol Rep       Date:  2010-04-22       Impact factor: 2.316

6.  Identification of androgen receptor splice variant transcripts in breast cancer cell lines and human tissues.

Authors:  Dong Gui Hu; Theresa E Hickey; Connie Irvine; Dhilushi Dodampege Wijayakumara; Lu Lu; Wayne D Tilley; Luke A Selth; Peter I Mackenzie
Journal:  Horm Cancer       Date:  2014-02-26       Impact factor: 3.869

Review 7.  Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?

Authors:  T E Hickey; J L L Robinson; J S Carroll; W D Tilley
Journal:  Mol Endocrinol       Date:  2012-06-28

8.  Novel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2-8) in Normal and Cancerous Breast and Prostate Cells.

Authors:  Dong Gui Hu; Ross A McKinnon; Julie-Ann Hulin; Peter I Mackenzie; Robyn Meech
Journal:  Int J Mol Sci       Date:  2016-12-27       Impact factor: 5.923

9.  Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer.

Authors:  Tae Woo Kim; Byungtak Kim; Ju Hee Kim; Seongeun Kang; Sung-Bin Park; Gookjoo Jeong; Han-Sung Kang; Sun Jung Kim
Journal:  BMC Cancer       Date:  2013-10-27       Impact factor: 4.430

10.  Phorbol esters from Jatropha meal triggered apoptosis, activated PKC-δ, caspase-3 proteins and down-regulated the proto-oncogenes in MCF-7 and HeLa cancer cell lines.

Authors:  Ehsan Oskoueian; Norhani Abdullah; Syahida Ahmad
Journal:  Molecules       Date:  2012-09-10       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.